A conserved dendritic-cell regulatory program limits antitumour immunity

Bárbara Maier(Icahn School of Medicine at Mount Sinai), Andrew M. Leader(Icahn School of Medicine at Mount Sinai), Steven T. Chen(Icahn School of Medicine at Mount Sinai), Navpreet Tung(Icahn School of Medicine at Mount Sinai), Christie Chang(Icahn School of Medicine at Mount Sinai), Jessica LeBérichel(Icahn School of Medicine at Mount Sinai), Aleksey Chudnovskiy(Rockefeller University), Shrisha Maskey(Icahn School of Medicine at Mount Sinai), Laura Walker(Icahn School of Medicine at Mount Sinai), John P. Finnigan(Icahn School of Medicine at Mount Sinai), Margaret E. Kirkling(Columbia University Irving Medical Center), Boris Reizis(New York University), Sourav Ghosh(Yale University), Natalie Roy D’Amore(AVEO Oncology (United States)), Nina Bhardwaj(Parker Institute for Cancer Immunotherapy), Carla V. Rothlin(Yale University), Andrea Wolf(Icahn School of Medicine at Mount Sinai), Raja M. Flores(Icahn School of Medicine at Mount Sinai), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Adeeb Rahman(Icahn School of Medicine at Mount Sinai), Ephraim Kenigsberg(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Miriam Mérad(Tisch Hospital)
Nature
March 25, 2020
10.1038/s41586-020-2134-y
Cited by 920Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis